# Illumina, Inc. – Consensus ‘hold’ rating and 35.0% Upside Potential

- Link: https://www.directorstalkinterviews.com/illumina-inc.consensus-hold-rating-and-35.0-upside-potential/4121126253
- Published: 2023-08-30T13:25:23+01:00
- Author: Charlotte Edwards

**Illumina, Inc.** with ticker code (ILMN) now have 19 market analysts covering 
the stock. The analyst consensus now points to a rating of ‘hold’. The target price
High/Low ranges between 329 and 135 calculating the mean target price we have $213.56.
Now with the previous closing price of $158.20 this would imply there is now a potential
upside of 35.0%. Also worth taking note is the 50 day moving average now sits at
$182.96 and the 200 moving average now moves to $203.94. The company has a market
cap of 25.63B. The stock price for the company is currently 161.93 USD

 The potential market cap would be $34,603,628,393 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 28.32 and
a -0.79% return on assets.

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic
and genomic analysis. The Company operates through two segments: Core Illumina and
GRAIL. Its Core Illumina segment offers products and services that serve customers
in the research, clinical and applied markets, and enable the adoption of a variety
of genomic solutions. Its GRAIL segment is a healthcare company focused on early
detection of multiple cancers. Its portfolio of integrated sequencing and microarray
systems, consumables, and analysis tools is designed to accelerate and simplify 
genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing
instruments, allowing customers to manage their biological sample and sequencing
runs, process and analyze the raw genomic data, and derive results. Its BeadArray
technology combines microscopic beads and a substrate in a proprietary manufacturing
process to produce arrays that can perform various assays simultaneously.

Share on: